| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2023-09-26 16:28:49 UTC |
|---|
| Updated at | 2025-02-11 15:44:26 UTC |
|---|
| NP-MRD ID | NP0331844 |
|---|
| Natural Product DOI | https://doi.org/10.57994/1255 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (+)-(6S,8S,7ʹS*) discorhabdin K methyl ester |
|---|
| Description | (+)-(6S,8S,7ʹS*) discorhabdin K methyl ester belongs to the class of organic compounds known as phenanthrolines. These are aromatic polycyclic compounds containing the phenanthroline skeleton, which is a derivative of phenanthrene, and consists of two pyridine rings non-linearly joined by a benzene ring. (+)-(6S,8S,7ʹS*) discorhabdin K methyl ester was first documented in 2023 (PMID: 37755087). Based on a literature review very few articles have been published on (+)-(6S,8S,7ʹS*) discorhabdin K methyl ester. |
|---|
| Structure | COC(=O)[C@@H](N)CC1=C(SC2=CC(=O)C=C3S[C@H]4C[C@@]23C2=C(N4)C(=O)C3=C4C(CC[NH+]=C24)=CN3)N=CN1C InChI=1S/C26H24N6O4S2/c1-32-10-30-24(14(32)7-13(27)25(35)36-2)38-16-6-12(33)5-15-26(16)8-17(37-15)31-22-19(26)20-18-11(3-4-28-20)9-29-21(18)23(22)34/h5-6,9-10,13,17,29,31H,3-4,7-8,27H2,1-2H3/p+1/t13-,17-,26-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C26H25N6O4S2 |
|---|
| Average Mass | 549.6400 Da |
|---|
| Monoisotopic Mass | 549.13732 Da |
|---|
| IUPAC Name | (3S,10S)-4-({5-[(2S)-2-amino-3-methoxy-3-oxopropyl]-1-methyl-1H-imidazol-4-yl}sulfanyl)-6,13-dioxo-9-thia-11,15,20-triazahexacyclo[12.6.1.1^{3,10}.0^{2,12}.0^{3,8}.0^{17,21}]docosa-1(20),2(12),4,7,14(21),16-hexaen-20-ium |
|---|
| Traditional Name | (3S,10S)-4-({5-[(2S)-2-amino-3-methoxy-3-oxopropyl]-1-methylimidazol-4-yl}sulfanyl)-6,13-dioxo-9-thia-11,15,20-triazahexacyclo[12.6.1.1^{3,10}.0^{2,12}.0^{3,8}.0^{17,21}]docosa-1(20),2(12),4,7,14(21),16-hexaen-20-ium |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC(=O)[C@@H](N)CC1=C(SC2=CC(=O)C=C3S[C@H]4C[C@@]23C2=C(N4)C(=O)C3=C4C(CC[NH+]=C24)=CN3)N=CN1C |
|---|
| InChI Identifier | InChI=1S/C26H24N6O4S2/c1-32-10-30-24(14(32)7-13(27)25(35)36-2)38-16-6-12(33)5-15-26(16)8-17(37-15)31-22-19(26)20-18-11(3-4-28-20)9-29-21(18)23(22)34/h5-6,9-10,13,17,29,31H,3-4,7-8,27H2,1-2H3/p+1/t13-,17-,26-/m0/s1 |
|---|
| InChI Key | XQCOYMGKBNPBHK-ZOXZPVQOSA-O |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| | Chemical Shift Submissions |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600.314502325, C2D6OS, simulated) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2024-05-03 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, DMSO, simulated) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2023-09-26 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, DMSO, simulated) | [email protected] | National Cancer Institute, MD, USA | Maria Orfanoudaki | 2023-09-26 | View Spectrum |
| | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Latrunculia kaakaariki | | |
|
|---|
| Chemical Taxonomy |
|---|
| Description | This compound belongs to the class of organic compounds known as phenanthrolines. These are aromatic polycyclic compounds containing the phenanthroline skeleton, which is a derivative of phenanthrene, and consists of two pyridine rings non-linearly joined by a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Phenanthrolines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Phenanthrolines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,7-phenanthroline
- Pyrroloquinoline
- Pyrrolo[4,3,2-de]quinoline
- Alpha-amino acid ester
- Alpha-amino acid or derivatives
- Indole or derivatives
- Aryl thioether
- Aryl ketone
- Tetrahydropyridine
- Fatty acid ester
- Vinylogous thioester
- Fatty acyl
- Alpha-branched alpha,beta-unsaturated-ketone
- Substituted pyrrole
- N-substituted imidazole
- Heteroaromatic compound
- Alpha,beta-unsaturated ketone
- Methyl ester
- Thiolane
- Secondary ketimine
- Pyrrole
- Enone
- Azole
- Acryloyl-group
- Cyclic ketone
- Thioenolether
- Ketone
- Carboxylic acid ester
- Amino acid or derivatives
- Formamidine
- Azacycle
- Sulfenyl compound
- Carboximidamide
- Hemithioaminal
- Secondary amine
- Monocarboxylic acid or derivatives
- Secondary aliphatic amine
- Carboxylic acid derivative
- Amidine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Amine
- Organic cation
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|